IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 183
Titolo Data di pubblicazione Autore(i) File
Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer 1-gen-2007 Martinelli, Erika; Morgillo, Floriana; Troiani, Teresa; Tortora, G; Cairdiello, F.
Combination of standard chemotherapy and targeted agents 1-gen-2007 Bareschino, Ma; Morgillo, Floriana; Ciardiello, Fortunato
Mechanisms of intrinsic and acquired resistance to EGFR inhibitors 1-gen-2007 Morgillo, Floriana; Tortora, G; Ciardiello, Fortunato
Combination of anti-EGFR drugs and other molecular targeted agents as anti-cancer strategy 1-gen-2007 Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Tortora, G; Ciardiello, Fortunato
Chronic inflammation and oxidative stress in human carcinogenesis 1-gen-2007 Federico, Alessandro; Morgillo, Floriana; Tuccillo, Concetta; Ciardiello, Fortunato; Loguercio, Carmelina
Erlotinib in cancer treatment 1-gen-2007 Bareschino, Ma; Schettino, C; Troiani, Teresa; Martinelli, Erika; Morgillo, Floriana; Ciardiello, Fortunato
Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib 1-gen-2007 Morgillo, Floriana; Kim, Wy; Kim, Es; Ciardiello, Fortunato; Hong, Wk; Lee, Hy
Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy 1-gen-2007 Morgillo, Floriana; Bareschino, Ma; Bianco, R; Tortora, G; Ciardiello, Fortunato
Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase Cbeta inhibitor, in non-small cell lung cancer cells 1-gen-2008 Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Laus, G; Pepe, S; Gridelli, C; Ciardiello, Fortunato
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells 1-gen-2008 Cascone, T; Morelli, Mp; Morgillo, Floriana; Kim, Wy; Rodolico, G; Pepe, S; Tortora, G; Berrino, Liberato; Lee, Hy; Heymach, Jv; Ciardiello, Fortunato
The use of xenograft models for the selection of cancer treatments with the EGFR as an example 1-gen-2008 Troiani, Teresa; Schettino, C; Martinelli, Erika; Morgillo, Floriana; Tortora, G; Ciardiello, Fortunato
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 1-gen-2008 Iovino, Francesco; Ferraraccio, Franca; Orditura, Michele; Antoniol, G.; Morgillo, Floriana; Cascone, T.; Diadema, M. R.; Aurilio, G.; Santabarbara, G.; Ruggiero, Roberto; Belli, C.; Irlandese, E.; Fasano, M.; Ciardiello, Fortunato; Procaccini, Eugenio; LO SCHIAVO, F.; Catalano, G.; DE VITA, Ferdinando
Resistance mechanisms of tumour cells to EGFR inhibitors 1-gen-2009 Morgillo, Floriana; Cantile, F; Fasano, M; Troiani, Teresa; Martinelli, Erika; Ciardiello, Fortunato
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC 1-gen-2009 Normanno, N.; Tejpar, S.; Morgillo, Floriana; DE LUCA, A.; VAN CUTSEM, E.; Ciardiello, Fortunato
Trimodality treatment in early-stage malignant pleural mesothelioma. Preliminary results of a multicenter phase II trial 1-gen-2010 Vicidomini, Giovanni; Curcio, C; Morgillo, Floriana; Fiorelli, Alfonso; Laperuta, P; Fasano, M; Lambiase, G; Cantile, F; Amore, D; Santini, Mario
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials 1-gen-2010 Gridelli, C; Morabito, A; Gebbia, V; Mencoboni, M; Carrozza, F; Viganò, Mg; Verusio, C; Bollina, R; Mattioli, R; Valerio, Mr; Valmadre, G; Maione, P; Rossi, A; Cascone, T; Morgillo, Floriana; DI MAIO, M; Piccirillo, Mc; Gallo, Ciro; Perrone, F; Ciardiello, Fortunato
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 1-gen-2010 Martinelli, Erika; Troiani, Teresa; Morgillo, Floriana; Rodolico, G; Vitagliano, D; Morelli, Mp; Tuccillo, C; Vecchione, L; Capasso, A; Orditura, Michele; DE VITA, Ferdinando; Eckhardt, Sg; Santoro, M; Berrino, Liberato; Ciardiello, Fortunato
Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: A phase II study 1-gen-2010 Orditura, Michele; Galizia, Gennaro; Napolitano, Vincenzo; Martinelli, Erika; Pacelli, R; Lieto, Eva; Aurilio, G; Vecchione, L; Morgillo, Floriana; Catalano, G; Ciardiello, Fortunato; DEL GENIO, A; DE VITA, Ferdinando
Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications. 1-gen-2011 Fiorelli, Alfonso; Vicidomini, Giovanni; DI DOMENICO, Marina; Napolitano, F; Messina, G; Morgillo, Floriana; Ciardiello, Fortunato; Santini, Mario
MEK inhibitor as a single agent and in combination with everolimus or sorafenib in a panel of colorectal cancer cell lines: implication for multitargeted approach 1-gen-2011 Martinelli, Erika; Troiani, Teresa; Morgillo, Floriana; Orditura, Michele; Capasso, A; D'Aiuto, E; Vecchione, L; DE PALMA, Raffaele; Ciardiello, Fortunato
Mostrati risultati da 21 a 40 di 183
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile